British Journal of Radiology

Aims & Scope

BJR is the international research journal of the British Institute of Radiology and is the oldest scientific journal in the field of radiology and related sciences.

Dating back to 1896, BJR’s history is radiology’s history, and the journal has featured some landmark papers such as the first description of CT "Computerized transverse axial tomography" by Godfrey Hounsfield in 1973.

A valuable historical resource, the complete BJR archive has been digitized from 1896.

BJR is an international, multi-disciplinary journal covering the clinical and technical aspects of medical imaging, radiotherapy, oncology, medical physics, radiobiology and the underpinning sciences.

BJR is essential reading for radiologists, medical physicists, radiation oncologists, radiotherapists, radiographers and radiobiologists.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.4
2024	1.80

SJR (SCImago Journal Rank)

Year	Value
2024	0.875

Quartile

Year	Value
2024	Q1

Journal Rank

Year	Value
2024	5940

Journal Citation Indicator

Year	Value
2024	3443

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Computerized transverse axial scanning (tomography): Part 1. Description of system

  Citation: 2819

  Authors: G. N.

• The linear-quadratic formula and progress in fractionated radiotherapy

  Citation: 1844

  Authors: John F.

• The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in Radiotherapy

  Citation: 1681

  Authors: L. H., A. D., M., S., O. C. A.

• Gold nanoparticles: a new X-ray contrast agent

  Citation: 1137

  Authors: J F, D N, T M, H M

• Whole Body Irradiation—Radiobiology or Medicine?

  Citation: 893

  Authors: R. H.

• Understanding breast cancer as a global health concern

  Citation: 890

  Authors: Louise, Toral

• Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response

  Citation: 854

  Authors: S R

• Gold nanoparticles as novel agents for cancer therapy

  Citation: 840

  Authors: S, D G, J M

• Cancer risks from diagnostic radiology

  Citation: 704

  Authors: E J, D J

• The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy

  Citation: 685

  Authors: R. G.

---